Tweet #375883143250595840
BoNTA-INC RC 2xblind phase3 trial for glabellar frown lines using a stringent composite endpoint ncbi.nlm.nih.gov/pubmed/23506308 #Merz #Bocouture
BoNTA-INC RC 2xblind phase3 trial for glabellar frown lines using a stringent composite endpoint ncbi.nlm.nih.gov/pubmed/23506308 #Merz #Bocouture